These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 19135984)

  • 1. ZIC1 is downregulated through promoter hypermethylation in gastric cancer.
    Wang LJ; Jin HC; Wang X; Lam EK; Zhang JB; Liu X; Chan FK; Si JM; Sung JJ
    Biochem Biophys Res Commun; 2009 Feb; 379(4):959-63. PubMed ID: 19135984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent promoter hypermethylation and transcriptional downregulation of BTG4 gene in gastric cancer.
    Dong W; Tu S; Xie J; Sun P; Wu Y; Wang L
    Biochem Biophys Res Commun; 2009 Sep; 387(1):132-8. PubMed ID: 19576178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
    Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C
    Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatin M expression is reduced in gastric carcinoma and is associated with promoter hypermethylation.
    Chen X; Cao X; Dong W; Xia M; Luo S; Fan Q; Xie J
    Biochem Biophys Res Commun; 2010 Jan; 391(1):1070-4. PubMed ID: 20004178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion.
    Kim M; Lee KT; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Kim SY; Yoo HS; Kim YS
    Mol Cancer Res; 2008 Feb; 6(2):222-30. PubMed ID: 18314483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent silencing of popeye domain-containing genes, BVES and POPDC3, is associated with promoter hypermethylation in gastric cancer.
    Kim M; Jang HR; Haam K; Kang TW; Kim JH; Kim SY; Noh SM; Song KS; Cho JS; Jeong HY; Kim JC; Yoo HS; Kim YS
    Carcinogenesis; 2010 Sep; 31(9):1685-93. PubMed ID: 20627872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer.
    Yu J; Liang QY; Wang J; Cheng Y; Wang S; Poon TC; Go MY; Tao Q; Chang Z; Sung JJ
    Oncogene; 2013 Jan; 32(3):307-17. PubMed ID: 22370639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation.
    Takada H; Imoto I; Tsuda H; Nakanishi Y; Ichikura T; Mochizuki H; Mitsufuji S; Hosoda F; Hirohashi S; Ohki M; Inazawa J
    Oncogene; 2005 Dec; 24(54):8051-60. PubMed ID: 16103878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of HLA class I gene is associated with HLA class I down-regulation in human gastric cancer.
    Ye Q; Shen Y; Wang X; Yang J; Miao F; Shen C; Zhang J
    Tissue Antigens; 2010 Jan; 75(1):30-9. PubMed ID: 19883394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer.
    Takada H; Wakabayashi N; Dohi O; Yasui K; Sakakura C; Mitsufuji S; Taniwaki M; Yoshikawa T
    Cancer Genet Cytogenet; 2010 Feb; 197(1):16-24. PubMed ID: 20113832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
    Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
    Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y; Tong D; Lou G; Zhang Y; Geng J
    Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma.
    Guo X; Liu W; Pan Y; Ni P; Ji J; Guo L; Zhang J; Wu J; Jiang J; Chen X; Cai Q; Li J; Zhang J; Gu Q; Liu B; Zhu Z; Yu Y
    Oncogene; 2010 Jul; 29(27):3908-20. PubMed ID: 20440264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.
    Carvalho AL; Chuang A; Jiang WW; Lee J; Begum S; Poeta L; Zhao M; Jerónimo C; Henrique R; Nayak CS; Park HL; Brait MR; Liu C; Zhou S; Koch W; Fazio VM; Ratovitski E; Trink B; Westra W; Sidransky D; Moon CS; Califano JA
    Cancer Res; 2006 Oct; 66(19):9401-7. PubMed ID: 17018594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis.
    Liu X; Wang X; Zhang J; Lam EK; Shin VY; Cheng AS; Yu J; Chan FK; Sung JJ; Jin HC
    Oncogene; 2010 Jan; 29(3):442-50. PubMed ID: 19881551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines.
    Shao L; Cui Y; Li H; Liu Y; Zhao H; Wang Y; Zhang Y; Ng KM; Han W; Ma D; Tao Q
    Clin Cancer Res; 2007 Oct; 13(19):5756-62. PubMed ID: 17908965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
    Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
    Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.